Founded in Princeton, New Jersey, Zena Therapeutics is a pharmaceutical company dedicated to developing innovative drugs for treating anxiety disorders and alcohol and substance use. Their core mission is to design and develop effective mental health and addiction therapeutics that prevent overdose fatalities and improve patient outcomes. By focusing on patient safety, Zena Therapeutics aims to ensure that medication misuse does not result in death.
Zena Therapeutics has garnered support from notable investors and industry experts committed to advancing mental health treatments. The company has made significant strides in drug discovery, contributing to the broader impact of reducing overdose fatalities and enhancing the quality of life for individuals struggling with addiction and anxiety disorders. Through their pioneering work, Zena Therapeutics is making a meaningful difference in the field of mental health and addiction treatment.
